These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8725902)

  • 1. Antibodies to amyloid beta protein (A beta) crossreact with glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
    Tamaoka A; Endoh R; Shoji S; Takahashi H; Hirokawa K; Teplow DB; Selkoe DJ; Mori H
    Neurobiol Aging; 1996; 17(3):405-14. PubMed ID: 8725902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein.
    Schulze H; Schuler A; Stüber D; Döbeli H; Langen H; Huber G
    J Neurochem; 1993 May; 60(5):1915-22. PubMed ID: 8473906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain.
    Sunaga K; Takahashi H; Chuang DM; Ishitani R
    Neurosci Lett; 1995 Nov; 200(2):133-6. PubMed ID: 8614562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
    Gerszon J; Rodacka A
    Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyloid precursor protein affects glyceraldehyde 3-phosphate dehydrogenase levels, organelle localisation and thermal stability.
    Delport A; Kins S; Hewer R
    Mol Biol Rep; 2020 Apr; 47(4):3019-3024. PubMed ID: 32152789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-β Amyloidogenesis in Alzheimer Disease.
    Itakura M; Nakajima H; Kubo T; Semi Y; Kume S; Higashida S; Kaneshige A; Kuwamura M; Harada N; Kita A; Azuma YT; Yamaji R; Inui T; Takeuchi T
    J Biol Chem; 2015 Oct; 290(43):26072-87. PubMed ID: 26359500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease.
    El Kadmiri N; Slassi I; El Moutawakil B; Nadifi S; Tadevosyan A; Hachem A; Soukri A
    Pathol Biol (Paris); 2014 Dec; 62(6):333-6. PubMed ID: 25246025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques.
    Takahashi H; Kurashima C; Utsuyama M; Hirokawa K
    Acta Neuropathol; 1990; 80(3):260-5. PubMed ID: 1698004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.
    Butterfield DA; Hardas SS; Lange ML
    J Alzheimers Dis; 2010; 20(2):369-93. PubMed ID: 20164570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures.
    Naletova I; Schmalhausen E; Kharitonov A; Katrukha A; Saso L; Caprioli A; Muronetz V
    Biochim Biophys Acta; 2008 Dec; 1784(12):2052-8. PubMed ID: 18725330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of glyceraldehyde 3-phosphate dehydrogenase (Gapdh) cDNA from the distal half of mouse chromosome 16: further indication of a link between Alzheimer's disease and glycolysis.
    Seipp S; Buselmaier W
    Neurosci Lett; 1994 Nov; 182(1):91-4. PubMed ID: 7891898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundance of the longer A beta 42 in neocortical and cerebrovascular amyloid beta deposits in Swedish familial Alzheimer's disease and Down's syndrome.
    Kalaria RN; Cohen DL; Greenberg BD; Savage MJ; Bogdanovic NE; Winblad B; Lannfelt L; Adem A
    Neuroreport; 1996 May; 7(8):1377-81. PubMed ID: 8856679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.
    Joachim CL; Duffy LK; Morris JH; Selkoe DJ
    Brain Res; 1988 Nov; 474(1):100-11. PubMed ID: 3214703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts.
    Mazzola JL; Sirover MA
    J Neurosci Res; 2003 Jan; 71(2):279-85. PubMed ID: 12503091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's paired helical filaments: amyloid precursor protein epitope mapping.
    Zemlan FP; Vogelsang GD; McLaughlin L; Dean GE
    Brain Res Bull; 1994; 33(4):387-92. PubMed ID: 7510209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease.
    Shalova IN; Cechalova K; Rehakova Z; Dimitrova P; Ognibene E; Caprioli A; Schmalhausen EV; Muronetz VI; Saso L
    Biochim Biophys Acta; 2007 May; 1770(5):826-32. PubMed ID: 17324518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.
    Mazzola JL; Sirover MA
    J Neurochem; 2001 Jan; 76(2):442-9. PubMed ID: 11208907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.